MedTrace Logo

Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4-RD

NCT04539197 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 660

Last updated 2020-09-04

No results posted yet for this study

Summary

300 IgG4-RD patients, 200 other autoimmune diseases, 60 IgG4-RD mimickers and 100 healthy controls were enrolled. Circulating plasmablast/plasma cells were detected of all patients at baseline and healthy controls. IgG4-RD patients were followed up every 3-6 months. Circulating plasmablast/plasma cells were also detected at disease remission and relapse. IgG4-RD patients' clinical data and laboratory parameters were collected.

Conditions

  • Plasmablast/Plasma Cells in Diagnosis of IgG4-RD
  • Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-10
Primary Completion
2022-06-10
Completion
2022-09-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04539197 on ClinicalTrials.gov